<?xml version="1.0" encoding="UTF-8"?>
<p id="para0011">The present review indicates that AT1R antagonists or vitamin D or a combination may be useful in treating the lung complication of COVID-19. Appropriately designed clinical studies are needed to establish the benefit of the combination of AT1R antagonists with vitamin D.</p>
